chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Low platelet count: On March 9th my blood platelet count was 240,000 On June 10th it was 86,000 June 14th- 84,000 June 21st- 112,000 & enlarged left auxiliary lymph nodes detected in physical exam by hematologist.  July 1st- 96,000 and a low white blood count of 3.0 July 13th- normal diagnostic mammogram. Ultrasound showed three enlarged lymph nodes, largest measuring 5.5cm.  July 15th- platelet count dropped to 84,000, wbc dropped to 2.5 July 19th- platelet count 71,000, wbc 2.0. Lymph node biopsy normal. Bone marrow biopsy normal.   No diagnosis.
Swelling at injection site by morning the swelling had gone to my finger tips, neck and face and breathing problems. I had to use an Epipen to take the swelling down and my inhaler for breathing.
dizzy spells; really really dizzy for 12 hours; severe dizziness standing or even sitting down; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (really really dizzy for 12 hours), DIZZINESS POSTURAL (severe dizziness standing or even sitting down) and DIZZINESS (dizzy spells) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20) for COVID-19 vaccination.     The patient's past medical history included Asthma since an unknown date and Blood pressure high since an unknown date. Concomitant products included EPINEPHRINE BITARTRATE (ASTHMAHALER) for Asthma.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jan-2021, the patient experienced DIZZINESS (really really dizzy for 12 hours) and DIZZINESS POSTURAL (severe dizziness standing or even sitting down). On an unknown date, the patient experienced DIZZINESS (dizzy spells). On 08-Jan-2021, DIZZINESS (really really dizzy for 12 hours) and DIZZINESS POSTURAL (severe dizziness standing or even sitting down) had resolved. At the time of the report, DIZZINESS (dizzy spells) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   patient is taking blood pressure medicine unknown drug no treatment information provided
This infant had a fever of 104 F the day of his vaccine. He then had a fever of 104 F, cough, stridorous retractions, hypoxic, requiring intubation for subglottic stenosis. 2 days after the vaccinations he was given IV antibiotics. Until cultures returned with negative results. He was found to be neutropenic. The patient developed DVT requiring anticoagulation.
Diffuse rash. Started on back of neck, spread down arms and legs. Bright red, papular, non-blanching. Not itching, no trouble breathing, no changes at site of vaccine, no complaints. Given Benadryl, but nothing changed.
Student had #1 HPV done at hospital 1/18/08 - 2/2 broke out in rash, on abdomen, lower back with pain.  Came to school 2/4.  Diagnosed with herpes zoster.  Treat with Zovirax for 7 days - labs drawn (nml) above reported ko Merck spec/ and med staff.  No contraindication #2 HPV.  #2 HPV given 4/4/08 - student returned 1 week later.
Hx miscarriage in August 2021. History of live birth September 2019. Miscarriage at 26October2921 after successful ovulation, positive pregnancy signs, positive home pregnancy test, and positive blood hcg test, then vagina bleeding and trending down hcg. I am (Privacy) so forced to get vaccine after mandate and miscarriage. I want to scream. I want someone held accountable for this killing! I want justice for my baby! I want the (Privacy) to suffer like I just did. I get no sick days or anything to grieve. I just continue to be an RN and watch others have successful pregnancies or go through miscarriages too.
sore arm; lightheaded and kind of dizzy; Her stomach doesn't feel great ("stomach isn't the best"); Dry mouth; nausea; This is a spontaneous report from a contactable consumer (patient). This 88-year old female patient received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 08Jan2021, for COVID-19 immunization. Medical history and concomitant medications were not reported. On 09Jan2021 the patient experienced sore arm. Since an unspecified date in Jan2021 she was lightheaded and kind of dizzy, her stomach did not feel great, she had dry mouth and nausea. She was feeling as if she could get sick (further specified as nausea). She had not got sick but her stomach wasn't the best. Events outcome was unknown. Information on the lot/batch number has been requested.
"Moderna COVID-19 Vaccine EUA". Approximately 8 hours after receiving the Moderna vaccine - very rapid heartbeat, weakness, difficulty breathing, feeling of having a heart attack, severe chest pain, pounding heart and shortness of breathe. On 1/7/22 - went to Emergency Room where blood work and two EKG's were done. Blood work showed a slightly elevated white blood cell count. EKG was normal.  On 1/12/22 - went to Emergency Room again where blood work, EKG and CAT scan were completed. Results were normal.  Still having tightness in chest along with feeling of heart pounding.
This is a spontaneous report from a non-contactable consumer via a Representative.   An elderly female patient (Non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE. Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on an unspecified date as a dose 2, single and received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported) dose 1 via an unspecified route of administration on an unspecified date as a dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Other vaccine received in four weeks and If COVID prior vaccination were unknown. Patient was tested for COVID post vaccination. The patient experienced break thru infection of covid virus. positive test on Jul2021. The patient underwent lab tests and procedures which included sars-cov-2 test that was positive on Jul2021 Break thru infection of covid virus. Positive test. Events resulted in the Doctor or other health care professional office/clinic visit. Events treatment included in the Infusion. Outcome of the event was recovering.  No Follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Moderna COVID-19 Vaccine EUA  Fever (101.6), chills, slight headache, joint and muscle pain, swelling and pain at site of injection, fatigue, difficulty falling asleep  Still have these reactions as of 4/20/01  5:45pm with temperature rising throughout day
Fever, body aches, chills, headache and neck aches. No energy or appetite. Drank fluids and slept most of day. Side effects diminished by evening and were completely gone by morning
Fever of 102-104 degrees from 6/13-17/03  Also had small papules (scattered, few) on face, then to trunk.  Had a couple of papules at site of MMR given on left leg.  Believed to be mild non-communicable measles.  No one else ill in home.  No exposure to prairie dogs, etc.  Rash resolving.  No other illness as per mother on 6/20/03.  Had induration, erythema, swelling on right leg at DTaP site 48 hours after DtaP given.  Delayed response -- localized, resolved after 2 days without ill effect.  Both vaccines were given on 6/6/03.
Patient has history of seizures and on Tegretol bid.  Afebrile and caretaker denied illness.  Child played all afternoon after receiving immunizations; had seizure at 3AM on 11/28/06.  Temp 101 degrees at 3AM.  Taken to ER and was released.  No additional seizure.  Mother stated that child had experienced a seizure x1 during the previous month of October.
Patient developed a fever the day after vaccines that measured 103. Tylenol was given, and the temperature dropped to 101. Patient was seen by physician for follow-up on 6/21/01.
Narrative: COVID infection after completion of COVID vaccine series: 03/01/2021 COVID vaccine dose #1 03/22/2021 COVID vaccine dose #2 07/13/2021 Pt reported onset of cough, HA, myalgia, and rhinorrhea. Stated had  close contact with COVID positive case (spouse) 07/18/2021 COVID positive per  07/22/2021 Pt reported improvement of most symptoms except for rhinorrhea 07/23/2021 Clinical resolution of COVID infection per guidelines
Individual reported feeling dizzy approximately 5 minutes after receiving injection.  Client diaphoretic and weak.  Client assisted into reclining chair and she ended up having a syncopal episode lasting approximately 20 seconds. Taken to Emergency Department for evaluation.  Oxygen level 100%, HR in low 40s and BP 80/52.
This spontaneous report as received from a medical assistant refers to about 5 patients of unknown age. The patient were vaccinated with a dose of GARDASIL (lot # not reported) stored as low as 31 F for an unknown period of time. No adverse effect was reported. Attempts are being made in order to obtain additional information to distinguish the individual patients mentioned in this report. Additional information has been requested.
General ache and tiredness, some tightness in throat by lymph glands, progressed to left underarm pain and swelling in afternoon and evening. Pain persisted in underarm area, some relief with TYLENOL and rest.
Pt vaccinated with first DTP/OPV several hrs later had persistent, unconsolable screaming/crying x 3 hrs.
Muscle weakness, slurred speech, paralysis of right side required hospitalization and rehab. Currently receiving physical and occupational therapy.
PATIENT HAD A STREAM OF BLOOD DOWN HER ARM UPON REMOVING SYRINGE AND SWOLLEN AREA/KNOT APPREARED WITH SLIGHT BRUISING LOOK.
SHINGRIX vaccine via the Subcutaneous route; This non-serious case was reported by a other health professional via call center representative and described the occurrence of intramuscular formulation administered by other route in a 52-year-old female patient who received Herpes zoster (Shingrix) (batch number C9Z43, expiry date 08-JUL-2024) for prophylaxis.   On 10-MAY-2023, the patient received Shingrix (subcutaneous, left arm) .5 ml. On 10-MAY-2023, an unknown time after receiving Shingrix, the patient experienced intramuscular formulation administered by other route (Verbatim: SHINGRIX vaccine via the Subcutaneous route). The outcome of the intramuscular formulation administered by other route was unknown.   Additional Information: GSK Receipt Date: 31-Mar-2023 Health care professional called to report an adult female received the Shingrix vaccine via the subcutaneous route on Wednesday, 10th May 2023, which led to intramuscular formulation administered by other route.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 09Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 53 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "hypothyroid" (unspecified if ongoing). Patient  had no known allergies. Concomitant medication(s) included: SYNTHROID, start date: 05Jun2014, stop date: 08Dec2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Positive covid test on day 8. Therapeutic measures were taken as a result of drug ineffective, covid-19. Patient received Paxlovid from 23Nov2022 to 27Nov2022 for COVID 19 Treatment.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
DARKENED VISION; LIGHT HEADED; COLD SWEATS; JOINT ACHE; CHILLS; MUSCLE ACHE; NAUSEA; HEADACHE; This spontaneous report received from a patient concerned a 21 year old of unspecified sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: not reported) dose was not reported, administered on 06-APR-2021 13:45 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 06-APR-2021 18:45, the subject experienced darkened vision. On 06-APR-2021 18:45, the subject experienced light headed. On 06-APR-2021 18:45, the subject experienced cold sweats. On 06-APR-2021 18:45, the subject experienced joint ache. On 06-APR-2021 18:45, the subject experienced chills. On 06-APR-2021 18:45, the subject experienced muscle ache. On 06-APR-2021 18:45, the subject experienced nausea. On 06-APR-2021 18:45, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from darkened vision, light headed, cold sweats, joint ache, chills, muscle ache, nausea, and headache on 07-APR-2021 13:00. This report was non-serious.
Got Bells Palsy 1 month and 9 days after my 2nd dose of vaccine. Was not sick before I got Bells Palsy. No signs of infection or viral infection. Not stressed out. No reasons why I got Bells Palsy, only thing different in my life was the vaccine.
Case number PHEH2012US022257 is an initial spontaneous report received from a pharmacist on 07 Nov 2012. This report refers to a 74-years-old male patient. He was vaccinated with MENVEO (batch number: A10062) intramuscularly on 25 May 2012. No adverse events were reported following the inadvertent administration.
Left arm became numb, improved in about two weeks. Right leg became numb and weak- last months.
Redness; Swelling; Pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (Pain), ERYTHEMA (Redness) and SWELLING (Swelling) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE, PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE (EQUATE ALLERGY & SINUS HEADACHE) for an unknown indication.    On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced PAIN (Pain). On 03-Apr-2021, the patient experienced ERYTHEMA (Redness) and SWELLING (Swelling). At the time of the report, PAIN (Pain), ERYTHEMA (Redness) and SWELLING (Swelling) outcome was unknown.            Patient's doctor told her to put ice on the area for 20 minutes and rub itching cream on it. (Avon moisture therapy anti-itch spray lotion)
tested positive with Covid-19; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: unknown; Expiration Date: unknown), dose 1 via an unspecified route of administration on 10Apr2021 as single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported.  On 20Apr2021 the patient tested positive with covid-19 (covid-19). The clinical outcome of the events was unknown. The patient is asking if she should get the second dose.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Information has been received from a physician concerning a 67 year old male patient who on 13-FEB-2007 was vaccinated with a first dose of ZOSTAVAX (Merck) (Lot number 656412/1476F) (Expiration date: JUN-2008). The physician reported that on 27-MAY-2010, the patient was diagnosed with shingles. The patient sought unspecified medical attention. At the time of this report, the patient's outcome was unknown. Follow-up information was received from a medical assistant who reported that on 13-FEB-2007 at 11:30, the male patient (weight: 220 pounds) was vaccinated intramuscularly with the first dose of ZOSTAVAX (Merck) at a age of 64 years old. The patient received the ZOSTAVAX (Merck) and still developed shingles. The patient did not require an emergency room/doctor visit. Follow up information has been received from a complete questionnaire. It was reported that on 13-FEB-2007 the patient with no history of chickenpox and no recent exposure to chicken pox was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck). There was no rash at the site of injection within 42 days of the vaccination. On 27-MAY-2010 the patient was diagnosed with herpes zoster. The pain the patient felt was of 7. It was also reported that the patient had a foot ulcer. On an unspecified date the patient recovered. No direct fluorescent antibody test was performed. No specimen was collected for polymerase chain reaction (PCR). No further information is expected.
Symptoms began approx 12 hrs after second injection.  Body aches, brain fog, exhaustion. light nausea, dizziness.  No fever.  Injection site was swollen, red, and hot to the touch.   Initial symptoms lasted about 12 hours.  Most of that time was spent sleeping.  My arm was sore  for about 4 days.  No other reactions and there was no reaction to the first injection.
Pt. is on ORTHO-CYCLEN. Last 2 menstrual periods 09/21/09 and 10/13/09. Pt. given H1N1 LAIV 11/2/09. Pt. was seen by FPC on 11/6/09. UPT + with estimated gestational age of 6-8 wks by exam. Medical records received for date 11/6/09. DX: IUP 6-8wks. Pt presented w/ absence of menses.
Patient experienced dizziness, lethargy, blurred vision and a fall without LOC following vaccine.
This case was reported by a nurse via call center representative and described the occurrence of sore throat in a patient who received BOOSTRIX. On 28th August 2017, the patient received BOOSTRIX. On 29th August 2017, 1 days after receiving BOOSTRIX, the patient experienced sore throat and elongated uvula. On an unknown date, the outcome of the sore throat was recovering/resolving and the outcome of the elongated uvula was unknown. It was unknown if the reporter considered the sore throat and elongated uvula to be related to BOOSTRIX. Additional details were provided as follows: The age at vaccination was not reported. The next day after vaccination, the patient woke up and felt like throat was sore and uvula was elongated. The healthcare professional had offered the patient to come into his office to be looked at, but the patient stated it was not necessary.
Urinary tract infection.  Symptoms started on May 7, 2022 - burning, frequency, pain upon urination.  Symptoms worsened on May 9, 2022 to include lower back and flank pain.  Visited urgent care at 9 AM on May 9, 2022.  UTI confirmed with point of care urinalysis.  Prescribed Cephalexin capsules 500 mg every 6 hours for 7 days.
Sweating, Nausea, flushed, treatment was IM Benadryl 50mg.
CoughWheeze & Tachycardia mild cough, tachycardia 100 -> 90 -> 80 (normal for employee is 70s).
Right upper arm sore & red, swollen- after 5 hours progresses to 5 x 3 cm reddened raised area with 8-12 cm non tender are surrounded no wheezing or asthma signs.
Ringing in her ears; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 67 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 09Apr2021 (Lot number: ER8734) at the age of 67 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Metastatic Breast Cancer" (unspecified if ongoing); "Rheumatoid Arthritis" (unspecified if ongoing); "Gastric Reflux" (unspecified if ongoing); "Osteoarthritis" (unspecified if ongoing); "hypothyroid" (unspecified if ongoing); "cancer and osteoporosis, mostly the cancer" (unspecified if ongoing); "cancer and osteoporosis, mostly the cancer" (unspecified if ongoing). Concomitant medication(s) included: LETROZOLE taken for breast cancer (ongoing); LEVOTHYROXINE taken for hypothyroidism (ongoing); PANTOPRAZOLE taken for reflux gastritis (ongoing); ATORVASTATIN taken for blood cholesterol abnormal (ongoing); BABY ASPIRIN taken for prophylaxis; PREDNISONE taken for rheumatoid arthritis (ongoing); OXYCODONE taken for breast cancer (ongoing); XGEVA taken for neoplasm malignant, osteoporosis (ongoing); COLACE; ADVIL. The following information was reported: TINNITUS (non-serious) with onset 09Apr2021, outcome "not recovered", described as "Ringing in her ears". Therapeutic measures were not taken as a result of tinnitus.  Additional Information: Patient reported that she has been taking letrozole about two years but could be off. Levothyroxine roughly 20 years. Pantoprazole been taking about say 10 years. Atorvastatin been taking for at least 10 years. Baby aspirin roughly 10 years maybe longer on that one. Prednisone been on that roughly a year and a half. Oxycodone been taking or about 2 years. she for-gets on that. Caller does not have dosage; been taking Xgeva for about a year and a half, She forgot again, they have changed her on that, she has been on it then off it then back on it. Further, stated within 5 to 10 minutes of getting the shot she had severe ringing in her left ear for about 20 seconds real strong. Patient states it went down to a lesser ringing but pretty much constant. Patient said that she does not know if she should have the second one because she heard that the symptoms are worse with the second dose. She said that she can tolerate the ringing now, but if it gets worse she does not know if she can tolerate it, especially if it was like the 20 seconds after she first received the vaccine. Patient states that she takes a lot of medications she will find her list to read them all. there is quite a bit. Patient also stated that, she takes Colace and Advil over the counter as needed. she takes vita-mins, just put down multivitamin should cover it. Patient also reported that, she is not taking any medications for the events she was experiencing.  No follow-up attempts are possible. No further information is expected.
Arm is swollen; Arm feels heavy; Arm is itching bad; This case was reported by a consumer via call center representative and described the occurrence of swelling arm in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th October 2019, the patient received Shingrix. In October 2019, less than a week after receiving Shingrix, the patient experienced swelling arm, heaviness in arm and itchy upper limbs. On an unknown date, the outcome of the swelling arm, heaviness in arm and itchy upper limbs were unknown.   It was unknown if the reporter considered the swelling arm, heaviness in arm and itchy upper limbs to be related to Shingrix.  Additional details were received as follows: The age at vaccination was not reported. The patient after vaccination had arm swelling, felt heavy and itching bad. The patient asked whether to consult a physician.
Information has been received from a pharmacist concerning a 20 year old female who on 4/9/01 was vaccinated with rubella virus vaccine live (second generation). Subsequently, the pt developed an immediate reaction with lips swelling, tightening of the airway and eyes swelling. The pt was given 25mg diphenhydramine hydrochloride (Benadryl), Im, and then 50mg IM. It was noted that the pulse oximeter check and respirations were "good". Upon internal review, the event was determined to be an "Other Important Medical Event". Additional information has been requested.